Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Berkel, J, Holcombe, RF, Middlebrooks, M & Kannan, K (1996). Non-steroidal anti-inflammatory drugs and colorectal cancer. Epidemiol Rev 18: 205–217.
Collet, J-P, Sharpe, C, Belzile, E, Boivin, J-F, Hanley, J & Abenhaim, L (1999). Colorectal cancer prevention by nonsteroidal antiinflammatory drugs: effects of dosage and timing. Br J Cancer 80: 00–00.
Gann, PH, Manson, JE, Glynn, RJ, Buring, JE & Hennekens, CH (1993). Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 85: 1220–1224.
Giovannuci, E, Egan, KM, Hunter, DJ, Stampfer, MJ, Colditz, GA, Willett, WC & Speizer, FE (1995). Aspirin and the risk of colorectal cancer in women. N Engl J Med 333: 609–614.
Marnett, LJ (1992). Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575–5589.
Sheng, H, Shao, J, Kirkland, SC, Isakson, P & Coffey, RJ (1997). Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99: 2254–2259.
Waddell, WR & Loughrey, RW (1983). Sulindac for polyposis of the colon. J Surg Oncol 24: 83–87.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Berkel, H. Does an ‘aspirin-a-day’ keep the doctor away?. Br J Cancer 81, 1–2 (1999). https://doi.org/10.1038/sj.bjc.6690641
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690641